SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran - Quaterly Results

29 Jul 2025 Evaluate
The quarter ended June 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 513.35 millions.The Net Profit of the company registered a slight decline of -17.15% to Rs. 35.18  millions from Rs. 42.46 millions.Operating Profit reported a sharp decline to 68.68 millions from 74.01 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 513.35 496.07 3.48 513.35 496.07 3.48 2710.10 3374.56 -19.69
Other Income 17.98 21.20 -15.19 17.98 21.20 -15.19 59.04 167.11 -64.67
PBIDT 68.68 74.01 -7.20 68.68 74.01 -7.20 445.60 536.37 -16.92
Interest 10.42 6.92 50.58 10.42 6.92 50.58 37.66 45.01 -16.33
PBDT 58.26 67.09 -13.16 58.26 67.09 -13.16 407.94 491.36 -16.98
Depreciation 12.19 11.97 1.84 12.19 11.97 1.84 49.99 46.20 8.20
PBT 46.07 55.12 -16.42 46.07 55.12 -16.42 357.95 445.16 -19.59
TAX 10.89 12.66 -13.98 10.89 12.66 -13.98 89.38 98.79 -9.53
Deferred Tax 0.09 -1.33 -106.77 0.09 -1.33 -106.77 3.06 -2.03 -250.74
PAT 35.18 42.46 -17.15 35.18 42.46 -17.15 268.57 346.37 -22.46
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.86 482.11 0.16
PBIDTM(%) 13.38 14.92 -10.33 13.38 14.92 -10.33 16.44 15.89 3.45

Kopran Share Price

154.40 -2.70 (-1.72%)
13-Apr-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1658.00
Dr. Reddys Lab 1227.55
Cipla 1211.55
Zydus Lifesciences 924.50
Lupin 2320.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×